When was AtheroMed founded?

AtheroMed was founded in 2006 and raised its 1st funding round 3 years after it was founded.

Where is AtheroMed located?

AtheroMed is headquartered in Menlo Park, United States.

Is AtheroMed a funded company?

AtheroMed is a funded company, having raised a total of $24.7M across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Oct 20, 2009.

When was the latest funding round of AtheroMed?

AtheroMed's latest funding was a $***** Series B round on Dec 10, 2013, with participation from 0 investor. Its primary sector is Cardiac and Vascular Disorders. In United States, the Cardiac and Vascular Disorders sector has seen $1.09B in funding in 2026 to date.

Where does AtheroMed rank among its competitors?

AtheroMed ranks 7th amongst 40 active competitors, of which 14 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Cagent Vascular, which secured $41M in May, 2026.

Who are the top competitors of AtheroMed?

AtheroMed's top competitors include Okami Medical, LeMaitre Vascular and Cagent Vascular. Among them, Cagent Vascular secured the most recent funding round in May, 2026.

AtheroMed - 2026 Company Profile, Funding & Competitors

Q: Is AtheroMed an acquired company?

AtheroMed got acquired by Volcano on May 27, 2014.

AtheroMed is an acquired company based in Menlo Park (United States), founded in 2006. It operates as a Peripheral atherectomy catheter for peripheral arterial disease. AtheroMed has raised $24.7M in funding. The company has 40 active competitors, including 14 funded and 11 that have exited. Its top competitors include companies like Okami Medical, LeMaitre Vascular and Cagent Vascular.

Company Details

Volcano AtheroMed develops Phoenix Atherectomy System used to treat peripheral artery disease. Volcano AtheroMed was formerly known as AtheroMed .In 2014, AtheroMed was acquired by Volcano corporation. Since then AtheroMed is known as Volcano AtheroMed. .

Website: atheromedinc.com
Social

Key Metrics

Founded Year

2006

Location

Menlo Park, United States

Stage

Acquired

Total Funding

$24.7M in 5 rounds

Latest Funding Round

Series B, Dec 10, 2013, $*****

Investors

Canaan & 3 more

Ranked

7^th among 40 active competitors

Similar Companies

Okami Medical & 48 more

Exit Details

Acquired by Volcano (May 27, 2014)

View AtheroMed's full profile

AtheroMed is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ATHEROMED INC CIN: 20-5241927 , United States, Active	Dec 31, 2005	-	-	-

AtheroMed got acquired by Volcano on May 27, 2014 at an acquisition amount of $*****.

Click here to take a look at AtheroMed's acquisition in detail

AtheroMed has raised a total funding of $24.7M over 5 rounds. Its first funding round was on Oct 20, 2009. AtheroMed has 4 institutional investors.

Here is the list of recent funding rounds of AtheroMed:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 10, 2013	5186929	Series B	3773953	5025228	8807125	4682806
Apr 02, 2013	2004717	Series B	3548036	5378805	7666457	2285127
Mar 21, 2012	2913950	Series A	8992930	7039956	4989693	6521730

Access funding benchmarks and valuations. Sign up today!

View details of AtheroMed's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of AtheroMed include Okami Medical, LeMaitre Vascular and Cagent Vascular. Here is the list of Top 10 competitors of AtheroMed, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Okami Medical 2011, Aliso Viejo (United States), Series F	Developer of innovative, versatile, and intuitive medical devices for peripheral vessels treatment	$107M	Gilde Healthcare, Vensana Capital & 6 others	62/100
2nd	LeMaitre Vascular 1983, Burlington (United States), Public	Vascular surgery solutions innovator, improving patient lives with thoughtfully designed devices	$5.83M	Royce Investment Partners, Conestoga Capital Advisors ... & 1 others	58/100
3rd	Cagent Vascular 2014, Wayne (United States), Series D	Developer of a device for removal of vascular blockages	$110M	USVP, Sectoral & 9 others	58/100
4th	Venturemed Group 2012, Toledo (United States), Series C	Developer of endovascular devices for the treatment of PAD and stenoses of AV fistulas and grafts	$72.2M	Endeavour Vision, RiverVest Venture Partners ... & 3 others	55/100
5th	Pathway Medical Technologies 1998, Kirkland (United States), Acquired	Provider of smart devices to clear peripheral arterial blockages	$102M	LVP, HLM Venture Partners & 8 others	52/100
6th	Avinger 2007, Redwood City (United States), Public	Provider of image-guided catheter-based products for peripheral artery disease	$171M	CRG, Emergent Medical Partners & 6 others	51/100
7th	AtheroMed 2006, Menlo Park (United States), Acquired	Peripheral atherectomy catheter for peripheral arterial disease	$24.7M	Canaan, Kaiser Permanente Ventures & 2 others	42/100
8th	Truvic 2014, Campbell (United States), Acquired	Developer of smart devices for peripheral vascular disease management	$5.89M	Ascension Ventures, AMED Ventures & 1 others	40/100
9th	Eximo Medical 2012, Rehovot (Israel), Acquired	Hybrid catheters for vascular procedures	$1.6M	Accelmed Ventures, Accelmed & 6 others	39/100
10th	Idev Technologies 2000, Houston (United States), Acquired	Self expanding stent system	$58.9M	Piper Jaffray, RiverVest Venture Partners ... & 3 others	39/100